Xue-Li Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xue-Li Li has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bei Guo
Department of Otolaryngology-Head and Neck Surgery, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Cai-Ling Chen
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Jin Ma
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Ke-Zhang Zhu
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Li Pan
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Nan Wang
Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 147-148
Erratum: Inflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):147-148. https://doi.org/10.4168/aair.2025.17.1.147
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 147-148
Open AccessErratum: Inflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):147-148. https://doi.org/10.4168/aair.2025.17.1.147
- 18 August 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (3) , 1107-1117
sPLA2GIB Promotes PGD2 and IL‐13 Production in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps
Objective: Secreted phospholipase A2 Group IB (sPLA2GIB) regulates the release of arachidonic acid, prostaglandins, and other inflammatory lipid mediators. Although it has been well involved in extensive inflammatory diseases, its specific mechanism in chronic rhinosinusitis with nasal polyps (CRSwNP) remains unclear. In this study, we investigated the role of sPLA2GIB in the pathophysiology of CRSwNP.Methods: Quantitative PCR, immunofluorescence staining, western blotting, and enzyme‐linked immunosorbent assay (ELISA) were used to analyze the expression of sPLA2s, phospholipase A2 receptor (PLA2R), and prostaglandin D2 (PGD2) in nasal samples. Human nasal epithelial cells (HNECs) were cultured at an air‐liquid interface (ALI) and stimulated with various cytokines. The human mast cell line HMC‐1 was stimulated with sPLA2GIB, and the expression of PGD2 and cytokines in the culture supernatant was detected by ELISA.Results: The mRNA and protein levels of sPLA2GIB were significantly higher in eosinophilic CRSwNP than in control tissues. sPLA2GIB was predominantly expressed in the nasal epithelial cells. PLA2R mRNA and protein levels were upregulated in both eosinophilic and non‐eosinophilic CRSwNP compared with the control groups. IL‐4, IL‐13, TNF‐α, and IL‐1β upregulated the expression of sPLA2GIB in ALI‐cultured HNECs. sPLA2GIB induced PGD2 and IL‐13 production in HMC‐1 cells in a hydrolytic activity‐independent manner. PGD2 protein expression was elevated in tissue homogenates of eosinophilic CRSwNP, and PGD2 upregulated the expression of IL‐13 in HMC‐1 cells.Conclusion: Increased secretion of sPLA2GIB by epithelial cells may promote eosinophilic inflammation in CRSwNP by enhancing PGD2 and IL‐13 production in mast cells via binding to PLA2R.Level of Evidence: N/A Laryngoscope, 134:1107–1117, 2024
- 18 August 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (3) , 1107-1117
sPLA2GIB Promotes PGD2 and IL‐13 Production in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps
Objective: Secreted phospholipase A2 Group IB (sPLA2GIB) regulates the release of arachidonic acid, prostaglandins, and other inflammatory lipid mediators. Although it has been well involved in extensive inflammatory diseases, its specific mechanism in chronic rhinosinusitis with nasal polyps (CRSwNP) remains unclear. In this study, we investigated the role of sPLA2GIB in the pathophysiology of CRSwNP.Methods: Quantitative PCR, immunofluorescence staining, western blotting, and enzyme‐linked immunosorbent assay (ELISA) were used to analyze the expression of sPLA2s, phospholipase A2 receptor (PLA2R), and prostaglandin D2 (PGD2) in nasal samples. Human nasal epithelial cells (HNECs) were cultured at an air‐liquid interface (ALI) and stimulated with various cytokines. The human mast cell line HMC‐1 was stimulated with sPLA2GIB, and the expression of PGD2 and cytokines in the culture supernatant was detected by ELISA.Results: The mRNA and protein levels of sPLA2GIB were significantly higher in eosinophilic CRSwNP than in control tissues. sPLA2GIB was predominantly expressed in the nasal epithelial cells. PLA2R mRNA and protein levels were upregulated in both eosinophilic and non‐eosinophilic CRSwNP compared with the control groups. IL‐4, IL‐13, TNF‐α, and IL‐1β upregulated the expression of sPLA2GIB in ALI‐cultured HNECs. sPLA2GIB induced PGD2 and IL‐13 production in HMC‐1 cells in a hydrolytic activity‐independent manner. PGD2 protein expression was elevated in tissue homogenates of eosinophilic CRSwNP, and PGD2 upregulated the expression of IL‐13 in HMC‐1 cells.Conclusion: Increased secretion of sPLA2GIB by epithelial cells may promote eosinophilic inflammation in CRSwNP by enhancing PGD2 and IL‐13 production in mast cells via binding to PLA2R.Level of Evidence: N/A Laryngoscope, 134:1107–1117, 2024
- Open Access
- 1 January 2021
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 13 (6) , 863-881
Inflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2021 Nov;13(6):863-881. https://doi.org/10.4168/aair.2021.13.6.863
- 1 January 2021
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 13 (6) , 863-881
Open AccessInflammatory Endotypes and Tissue Remodeling Features in Antrochoanal Polyps
Chen CL, et al. Allergy Asthma Immunol Res. 2021 Nov;13(6):863-881. https://doi.org/10.4168/aair.2021.13.6.863